Results: 740

Guideline for the management of bile duct cancers by the brazilian gastrointestinal tumor group

Arq. gastroenterol; 53 (1), 2016
ABSTRACT The Brazilian Gastrointestinal Tumor Group developed guidelines for the surgical and clinical management of patients with billiary cancers. The multidisciplinary panel was composed of experts in the field of radiology, medical oncology, surgical oncology, radiotherapy, endoscopy and pathology. T...

Surgery versus endoscopic therapies for early cancer and high-grade dysplasia in the esophagus: a systematic review

Arq. gastroenterol; 53 (1), 2016
ABSTRACT Background Esophageal cancer occurs as a local disease in 22% of cases, and a minority of this disease is limited to the mucosa or submucosa (early lesions). Endoscopic mucosal resection, endoscopic submucosal dissection, photodynamic therapy, laser therapy, and argon plasma coagulation have em...

Esophageal carcinoma: is squamous cell carcinoma different disease compared to adenocarcinoma? A transversal study in a quaternary high volume hospital in Brazil

Arq. gastroenterol; 53 (1), 2016
ABSTRACT Background Esophageal cancer is one of the leading causes of mortality among the neoplasms that affect the gastrointestinal tract. There are several factors that contribute for development of an epidemiological esophageal cancer profile in a population. Objective This study aims to describe bo...

Seguridad y eficacia de lapatinib en combinación con capecitabina en el tratamiento de cáncer de mama metastásico HER2 positivo, refractario a tratamiento de primera línea con esquemas de quimioterapia asociados a trastuzumab, en pacientes con metástasis cerebral controlada

INTRODUCCIÓN: El presente informe expone la evaluación del medicamento lapatinib en combinación con capecitabina, para pacientes con cáncer de mama metastásico con receptor HER2 positivo, refractarios a tratamiento de primera línea con esquemas de quimioterapia asociados a trastuzumab, con metásta...

Brazilian data of renal cell carcinoma in a public university hospital

Int. braz. j. urol; 42 (1), 2016
ABSTRACT Purpose Among renal malignancies, renal cell carcinoma (RCC) accounts for 85% of cases. Stage is a relevant prognostic factor; 5-year survival ranges from 81% to 8% according to the stage of disease. The treatment is based on surgery and molecularly targeted therapy has emerged as a choice for...

Educational program on fatigue for brain tumor patients: possibility strategy?

Arq. neuropsiquiatr; 74 (2), 2016
ABSTRACT Objective To evaluate the effectiveness of an educational program on improvement of fatigue and quality of life of patients with high-grade glioma during radiotherapy and chemotherapy treatment. Method This is a longitudinal, experimental study. Twenty-three patients with high-grade glioma were ...

Beneficio de la quimioterapia adyuvante en pacientes con cáncer de colon: cohorte retrospectiva de un hospital clínico universitario

Rev. méd. Chile; 144 (2), 2016
Background: Multiple clinical trials have demonstrated the benefits of adjuvant 5-fluorouracil-based chemotherapy for patients with resectable colon cancer (CC), especially in stage III. Aim: To describe the clinical characteristics of a cohort of CC patients treated at a single university hospital in Ch...

Detección precoz de cáncer pulmonar con tomografía computarizada de tórax en pacientes con enfermedad pulmonar obstructiva crónica tabáquica

Rev. méd. Chile; 144 (2), 2016
Background: Chest computed tomography (CT) scan may improve lung cancer detection at early stages in high risk populations. Aim: To assess the diagnostic performance of chest CT in early lung cancer detection in patients with chronic obstructive pulmonary disease (COPD). Patients and Methods: One hundred...

Seguridad y eficacia de pertuzumab en combinación con trastuzumab y docetaxel en el tratamiento neoadyuvante de cancer de mama localmente avanzando en pacientes com receptores HER2 positivo, que no hayan recibido tratamiento previo
Safety and efficacy of pertuzumab in combination with trastuzumab and docetaxel in neoadjuvant treatment of locally advanced breast cancer in patients with HER2-positive receptors who have not received prior treatment

INTRODUCCIÓN: Antecedentes: El presente informe expone la evaluación de la combinación de pertuzumab, trastuzumab y quimioterapia basada en taxanos como terapia neoadyuvante en pacientes con cáncer de mama localmente avanzado HER2 positivo. Aspectos Generales: El cáncer de mama es el cáncer más f...

Acesso a diagnóstico e tratamento de paciente com câncer de mama e colo uterino no Brasil: Análise dos dados dos registros hospitalares de câncer

Câncer de mama e de colo uterino são patologias responsáveis por morbidade e mortalidade significativas. Ambas as doenças apresentam prognóstico reservado quando o diagnóstico é feito em estágios avançados. O objetivo do presente trabalho foi estudar os fatores relacionados com o estadiamento de...